Dose Escalation and Dosimetry of First in Human Alpha Radioimmunotherapy with (212)Pb-TCMC-trastuzumab

Por Meredith, Ruby, Torgue, Julien, Shen, Sui, Fisher, Darrell R., Banaga, Eileen, Bunch, Patty, Morgan, Desiree, Fan, Jinda, Straughn, J. Michael
Publicado no J Nucl Med (2014)

Toxicological Studies of (212)Pb Intravenously or Intraperitoneally Injected into Mice for a Phase 1 Trial

Por Milenic, Diane E., Molinolo, Alfredo A., Solivella, María S., Banaga, Eileen, Torgue, Julien, Besnainou, Sarah, Brechbiel, Martin W., Baidoo, Kwamena E.
Publicado no Pharmaceuticals (Basel) (2015)

Pharmacokinetics and Imaging of (212)Pb-TCMC-Trastuzumab After Intraperitoneal Administration in Ovarian Cancer Patients

Por Meredith, Ruby F., Torgue, Julien, Azure, Michael T., Shen, Sui, Saddekni, Souheil, Banaga, Eileen, Carlise, Ronda, Bunch, Patty, Yoder, Daniel, Alvarez, Ronald
Publicado em 2014